Biocon Shares Surge as Company Posts ₹84.5 Crore Profit in Q2 FY26, Biosimilars Drive Turnaround
Biocon Ltd., India’s leading biopharmaceutical company, has reported a sharp turnaround in its financial performance for the second quarter of FY26, swinging to a consolidated net profit of ₹84.5 crore from a loss of ₹16 crore in the same period last year. The Bengaluru-based firm’s strong results were driven by robust growth in its biosimilars…